Tech Update: CADRC Enhances Research with Digital Slide Scanner - Cleveland Alzheimers Disease Research Center The Cleveland Alzheimer’s Disease Research Center (CADRC) enhances its diagnostic capabilities with a new digital slide scanner. Learn how high-resolution digital imaging at the National Prion Disease...

Tech Update: The CADRC has purchased a new digital slide scanner. 🔬

Housed at the NPDPSC at CWRU, it converts glass slides into high-res digital images for better analysis and collaboration. This moves us closer to AI-driven pathology workflows.

#CADRC #CWRU #DigitalPathology

Targeting Astrocyte Dysfunction: Dr. Benjamin L.L. Clayton Awarded Grant to Study Alexander Disease Mechanisms - Cleveland Alzheimers Disease Research Center Understanding the mystery of the astrocyte: CADRC REC scholar Dr. Benjamin L.L. Clayton investigates new therapeutic targets for the rare genetic Alexander Disease.

🔬 How do astrocyte mutations cause brain damage? CADRC REC scholar Dr. Benjamin Clayton is on the case.

With @CWRU & the End Alexander Disease Foundation, his lab is finding ways to restore gene activity and protect white matter in children. #RareDisease #Neuroscience #CADRC #AlexanderDisease

New NIA Grant Awarded to Dr. Tian Liu to Investigate Mitochondrial Links to Alzheimer’s Pathology - Cleveland Alzheimers Disease Research Center Could CHCHD10 be the key to stopping Alzheimer’s? CADRC REC alumni Dr. Tian Liu launches NIA-funded research into tau aggregates and mitochondrial health.

Congratulations to CADRC REC alumnus, who was awarded a two-year NIA Grant to investigate mitochondrial links to Alzheimer’s pathology.
#ENDALZ #alzheimers #brainhealth #CADRC

CADRC Researchers find that Alzheimer’s Disease Can Be Reversed in Animal Models For generations, the medical world has operated under a sobering assumption: once Alzheimer’s disease takes hold, the damage to the brain is permanent. Research has traditionally focused on building "roadblocks" to slow the disease down, rather than finding a way to turn the car around. However, a transformative new study led by Kalyani Chaubey, PhD, in the laboratory of CADRC co-Investigator…

Big news in Alzheimer’s research! A new study led by Kalyani Chaubey, PhD, in the lab of CADRC co-Investigator Dr. Andrew Pieper, is challenging 100 years of medical dogma. #AlzheimersResearch #BrainHealth #MedicalBreakthrough #Hope #CADRC #Neuroscience